Adjuvant pomegranate juice consumption improves the inflammatory standing of hospitalized COVID-19 sufferers.
PMID:
Complement Ther Med. 2023 Aug ;75:102958. Epub 2023 Jun 3. PMID: 37271189
Summary Title:
Adjuvant pomegranate juice consumption improves the inflammatory standing of hospitalized COVID-19 sufferers: A randomized and placebo-controlled trial.
Summary:
BACKGROUND: This research aimed to judge the impact of pomegranate juice consumption on the inflammatory standing and full blood rely in hospitalized Covid-19 sufferers.METHODS: This randomized, double-blinded placebo-controlled trial included 48 sufferers with two parallel arms. Along with the usual care supplied on the hospital, the sufferers consumed 500 mL of complete pomegranate juice (PJ) every day or a placebo for 14 days. Inflammatory markers (C-reactive protein (CRP), interleukin-6 (IL-6), erythrocyte sedimentation fee (ESR)) and full blood rely had been decided at baseline and after the 14 days of intervention.RESULTS: On the finish of the intervention, a big decreased was noticed in main outcomes [mean difference (95 %CI)] together with IL-6 [5.24(0.87-9.61)]CRP [23.19(11.93-34.44)] and ESR [10.52(1.54-19.50)] within the PJ group vs. earlier than the intervention. As well as, vital modifications had been additionally noticed within the a few of the secondary outcomes, together with neutrophils, lymphocytes, platelets, platelets-to-lymphocyte(PLR) and neutrophils-to-lymphocyte (NLR) ratios (p
